Home › Funds › a16z Capital Management, L.L.C. › NAUT

a16z Capital Management, L.L.C. position in NAUT

NAUTILUS BIOTECHNOLOGY INC · Industrials

a16z Capital Management, L.L.C. reported holding 9,063,054 shares of NAUT (NAUTILUS BIOTECHNOLOGY INC) in its Q2 2026 13F filing — a position valued at US$16.9M, representing 0.12% of its reported portfolio and ranking #12 among its reported holdings. a16z Capital Management, L.L.C. has disclosed NAUT holdings in 11 of the last 11 reported quarters, going back to Q4 2023.

Latest position (Q2 2026)9.06M sh
Reported value held$16.95M
Portfolio Weight0.12%
First reportedQ4 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How a16z Capital Management, L.L.C.'s NAUT position evolved

a16z Capital Management, L.L.C. first disclosed a stake in NAUT in Q4 2023 at 17,653,917 shares (US$52.8M). The position peaked in Q1 2026 at 17,653,917 shares, worth US$68.5M. Across 11 filings, a16z Capital Management, L.L.C. increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 9 time(s). The most recent filing (Q2 2026) shows 9,063,054 shares valued at US$16.9M — a reduction of -8,590,863 shares quarter over quarter.. Notable position changes include a 49% trim in Q2 2026 (shares fell 24% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2023 17.65M $52.79M New
Q1 2024 17.65M $51.90M Hold
Q2 2024 17.65M $41.31M Hold
Q3 2024 17.65M $50.31M Hold
Q4 2024 17.65M $29.66M Hold
Q1 2025 17.65M $15.20M Hold
Q2 2025 17.65M $12.80M Hold
Q3 2025 17.65M $14.92M Hold
Q4 2025 17.65M $34.43M Hold
Q1 2026 17.65M $68.50M Hold
Q2 2026 9.06M $16.95M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About NAUT and 13F data

NAUT (NAUTILUS BIOTECHNOLOGY INC) is a Industrials company. 33 other funds we track also report a position in NAUT — the largest reported positions include Cercano Management LLC (US$13.4M), Comprehensive Financial Management LLC (US$4.1M), HILLMAN CO (US$374K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding NAUT

All NAUT fund holders →

FAQ

How long has a16z Capital Management, L.L.C. held NAUT?

a16z Capital Management, L.L.C. has disclosed NAUT holdings in 11 of the last 11 reported quarters, going back to Q4 2023.

What is a16z Capital Management, L.L.C.'s current position in NAUT?

As of Q2 2026, a16z Capital Management, L.L.C. holds 9.06M shares of NAUT (NAUTILUS BIOTECHNOLOGY INC), valued at $16.95M, representing 0.12% of its reported portfolio and ranking #12.

Has a16z Capital Management, L.L.C. been buying or selling NAUT?

In the latest 13F filing (Q2 2026), a16z Capital Management, L.L.C. reduced its position in NAUT. The position peaked in Q1 2026 at 17.65M shares.

Which other funds hold NAUT?

Other major institutional holders of NAUT include Cercano Management LLC, Comprehensive Financial Management LLC, HILLMAN CO, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.